A novel bi-alleleic DDX41 mutations in B-cell lymphoblastic leukemia: case report.

Woo Yong ShinSeug Yun YoonRojin ParkJung-Ah KimHo Hyun SongHae In BangJong-Ho WonJieun Kim

Published in: BMC medical genomics (2022)

We report that DDX41 mutations are unusual but can be an underlying event in Ph + B-ALL and screening DDX41 mutations can be also informative for patients awaiting for haploidentical stem cell transplantation and choosing the therapy.

Keyphrases

stem cell transplantation
high dose
end stage renal disease
case report
bone marrow
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
acute myeloid leukemia
peritoneal dialysis
stem cells
low dose
cell therapy